Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 February, 2019 05:46 IST
Suven Life Sciences presents clinical data at Neuroscience 2018
Source: IRIS | 05 Nov, 2018, 12.11PM
Comments  |  Post Comment

Suven Life Sciences announced that the company is participating and presenting positive Pre-clinical and Phase-1 clinical data of several advanced molecules from their portfolio of new chemical entities (NCEs) and the status of Phase 2 clinical trial of their lead compound SUVN-502 at Neuroscience 2018, organized by Society for Neuroscience being held at San Diego, USA during 4 to 7 November 2018.

Neuroscience is the annual meeting of the Society for Neuroscience (SFN) and more than 30 thousand Neuro-Scientists from all over the world covering the major Pharma, Biotech and Clinical Research institutes will be participating at this conference.

Shares of the company gained Rs 0.65, or 0.27%, to trade at Rs 237.40. The total volume of shares traded was 42,838 at the BSE (12.02 p.m., Monday).



Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Aarti Industries signs USD 125 mn multi-year deal - 20-Feb-2019 10:53
Glenmark to present data on Ryaltris at AAAAI 2019 - 20-Feb-2019 10:48
Fitch rates STFC's USD senior secured bonds 'BB+(EXP)' - 20-Feb-2019 10:33
ABB bags train technologies order worth Rs 2.70 bn - 20-Feb-2019 10:30
Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics - 19-Feb-2019 10:58
Glenmark Pharma receives ANDA approval for Clobetasol propionate foam - 18-Feb-2019 10:45
L&T Construction secures contract for design and construction of major airport - 18-Feb-2019 10:42
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer